EGFR and lung carcinoma: In this study, we retrospectively analyzed the efficacy of ICI in patients with EGFR gene mutation‐positive lung cancer who received ICI treatment after treatment with EGFR‐TKIs and evaluated the relationship between ICI treatment period and characteristics including EGFR subtype and treatment period of previous EGFR‐TKIs.